Bristol Myers Squibb (BMYMP) Non-Current Assets (2016 - 2025)
Historic Non-Current Assets for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $60.6 billion.
- Bristol Myers Squibb's Non-Current Assets fell 346.21% to $60.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $245.0 billion, marking a year-over-year decrease of 807.81%. This contributed to the annual value of $60.6 billion for FY2025, which is 346.21% down from last year.
- As of Q4 2025, Bristol Myers Squibb's Non-Current Assets stood at $60.6 billion, which was down 346.21% from $61.3 billion recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Non-Current Assets ranged from a high of $85.3 billion in Q1 2021 and a low of $60.6 billion during Q4 2025
- Over the past 5 years, Bristol Myers Squibb's median Non-Current Assets value was $67.5 billion (recorded in 2023), while the average stood at $68.9 billion.
- In the last 5 years, Bristol Myers Squibb's Non-Current Assets plummeted by 1454.57% in 2022 and then surged by 471.31% in 2024.
- Bristol Myers Squibb's Non-Current Assets (Quarter) stood at $76.1 billion in 2021, then decreased by 8.55% to $69.5 billion in 2022, then fell by 8.85% to $63.4 billion in 2023, then fell by 0.89% to $62.8 billion in 2024, then decreased by 3.46% to $60.6 billion in 2025.
- Its Non-Current Assets was $60.6 billion in Q4 2025, compared to $61.3 billion in Q3 2025 and $61.5 billion in Q2 2025.